Palantir platform unused by 29 hospital trusts NHS says have benefited
Reported by The Guardian1 source ↓
The Guardian reports that 29 trusts listed by NHS England as benefiting from Palantir’s data platform said it was not live or they were not using its applications. NHS England says trusts have reported benefits, including from tools used for back-office work.
Key points
- NHS England lists 137 trusts as live with the platform
- NHS England says it cannot prove the platform caused a reported rise in operations
- MPs have called for the contract to be ended or opened to competition
- The contract has a break clause in 2027
Details
The Guardian’s findings are based on more than 100 freedom of information requests obtained by the medical charity Medact. Among the trusts listed as benefiting, some said the platform was not live, no implementation timeline had been agreed, or they did not plan to roll it out.
NHS England says nearly 140 trusts have reported benefits from the platform’s tools. It has said the list includes trusts using tools for back-office data analysis and data submission, rather than patient care; some trusts described as not operationally using the system may use a small part of it to calculate treatment costs.
NHS England has also claimed that trusts using the platform carried out 117,539 more operations in a year, but previously acknowledged it could not prove cause and effect. The Office for Statistics Regulation said it would take the claims about trusts “realising benefits” forward through its casework.
Palantir’s UK and Europe chief executive said ending the deal would put politics above patients; the company says its software is helping improve care.
Written from coverage as of
Stocks in this story
Change since open: 20 Nov to 21 Nov 2026
Last refresh